Hur, 허, Lee, 이, Kang, 강, Lee, and 이: Campylobacter fetus Peritonitis in a Patient with Continuous Ambulatory Peritoneal Dialysis: A First Case Report in Korea

Kyuhwa Hur1Eunyoung Lee1Jongmyeong Kang2Yangsoon Lee1*

1Departments of Laboratory MedicineKorea
2Internal Medicine,Hanyang University College of MedicineKorea


*Corresponding author: Tel: +82-2-2290-9655, Fax: +82-2-2290-9193, E-mail: yangsoon@hanyang.ac.kr


ABSTRACT

Campylobacter fetus may cause infections such as septicemia, peritonitis, meningitis, endocarditis, septic arthritis, and cellulitis, increasing the risk of spontaneous abortion but decreasing the likelihood of gastroenteritis. We identified C. fetus from continuous ambulatory peritoneal dialysis (CAPD) fluid using 16S rRNA gene sequencing. It is significant that this is the first case report in Korea of CAPD peritonitis caused by C. fetus, which is known to be rare. (Ann Clin Microbiol 2018;21:20-22)

Keywords



INTRODUCTION

Campylobacter spp. can cause either gastrointestinal or extra- intestinal infections [1]. Although acute diarrheal illnesses are most common in Campylobacter jejuni, another Campylobacter spp., especially C. fetus may cause infections in virtually all parts of the body including septicemia, peritonitis, meningitis, endocarditis, septic arthritis, cellulitis and abortion more likely and gastroenteritis less likely [1-3]. C. fetus has been reported especially in patients with AIDS or other immunocompromised patients [1,3]. The cases of continuous ambulatory peritoneal dialysis (CAPD) infection caused by C. fetus have rarely been reported in global [3-7], especially the first case in Korea.

The objective of this study was to evaluate the accuracy of QMAC-dRAST AST system with faster protocol for staphylococci and enterococci cocci isolates originated from blood culture bottles. The accuracy was compared to that from MicroScan WalkAway plus system, commonly used as an automated AST system.

CASE REPORT

The patient was 73 year old with diabetes mellitus and chronic kidney disease (CKD) for 16 years and underwent CAPD for 2 years. He was admitted to the nephrology department with a 4-day history of abdominal pain, nausea and vomiting. CAPD peritonitis was suspected by the analysis of following tests at the time of admission. Laboratory tests showed a leukocyte count of 14,200/μL (segmented neutrophil 74.2%, lymphocytes 11.5%, monocytes 10.4%), and C-reactive protein (CRP) level of 9.1 mg/dL. And CAPD fluid contained 840/μL WBC with 85% polymorphonuclear cells. Cefazoline and ceftazidime treatment were started for empirical intraperitoneal antibiotics.

On the day of admission, Gram stain of the CAPD fluid was negative. But, CAPD fluid culture using blood bottles, C. fetus was identified. CAPD fluid cultures were inoculated using BacT/ALERT 3D (bioMérieux, Marcy-l’Etoile, France). On the third day of culture, bacterial growth was detected and Gram-negative curved rods were observed. The bacteria were cultivated in a Campy Blood-Free Selective Media agar medium (Asan, Seoul, Korea). The bacteria grew at 35°C at the duration of 2 days, but not grew in a micro-aerobic environment at 42°C. The results of the additional identification test on the colony are as follows: oxidase test was positive, hippurate hydrolysis test was negative, and cephalothin was susceptible. For further identification of bacterial species, polymerase chain reaction (PCR) for 16S rRNA gene sequencing was carried out. The universal primers 27F (5′-AGAGTTTGATCCTGGCTCAG-3′) and 1492R (5′-GGTTACCTTGTTACGACTT-3′) were used to amplify parts of the 16S rRNA gene. The strain was the most closely matched to that of C. fetus subsp. fetus ATCC27374 (GenBank accession number NR043597.1) with 99.9% identity (1314/1315 bp). Antimicrobial susceptibility testing was performed by E-test and interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [9]. The medium used was Mueller-Hinton agar with 5% sheep blood. The plates were incubated in a micro-aerobic environment for 24 hours at 35°C. The antimicrobial materials used were ciprofloxacin and erythromycin. C. fetus was both susceptible to ciprofloxacin (minimum inhibitory concentration=0.25 μg/mL) and erythromycin (0.38 μg/mL). Additional treatment using ciprofloxacin was started. After 2 weeks of intraperitoneal antibiotic treatment, the patient's symptoms was improved and discharged.

However, four months later, the patient was readmitted with abdominal pain and cloudy dialysate from 3 days before admission. CAPD peritonitis was recurrently diagnosed at the time of admission from the analysis of following tests. Laboratory tests showed leukocyte count of 11,600/μL (segmented neutrophil 64.0%, lymphocytes 17.4%, monocytes 9.6%) and CRP level of 9.0 mg/dL. CAPD fluid contained 40/μL WBC with 80% polymorphonuclear cells. The patient underwent intraperitoneal antibiotics treatment with cefamezin and ceftazidime in the CAPD transfer set. However, at that time, Gram stain and culture of the CAPD fluid were negative. After 10 days of intraperitoneal antibiotic treatment, patient symptoms and test results improved, outpatient follow-up and peritoneal dialysis has been maintained after discharge.

DISCUSSION

There have been so many different species causing CAPD infection. Most series have found coagulase-negative staphylococci to be the most frequently encountered agents (40% to 60%), followed by S. aureus and streptococcus spp. (10% to 20% each), Enterobacteriaceae (5% to 20%), nonfermentative gram-negative rods (3% to 15%), and gram-positive rods (2% to 4%). Values for mixed bacteria, fungi, mycobacteria, and anaerobes are generally <5% [4].

Campylobacter spp. can be detected by Gram stain examination from a colony on a primary isolation plate. They have characteristic microscopic morphology: small, curved or seagull- winged gram-negative rods [1]. If the colony is suspicious- looking at Campylobacter spp., it must be cultured to selective agars and incubated at 35°C in a micro-aerobic atmosphere. To identify species of Campylobacter spp., the incubation of three inoculated plates at 42°C, 35°C and 25°C should be required because they have different optimum temperatures [10]. C. coli and C. jejuni could grow at 42°C, but C. fetus could not. In this case, C. fetus isolate showed poorly growth at 42°C but well growth at 35°C. Also, susceptibility to nalidixic acid and cephalothin is an important differential characteristic among species. Molecular assays using PCR-based amplification of the 16S rRNA gene and direct sequencing of the PCR product have successfully identified the majority of Campylobacter species. C. fetus is generally susceptible to many antibiotics: erythromycin is the regimen of choice, with ciprofloxacin as an alternative drug [1,11]. The rate of resistance to erythromycin was about under 10% in Korea. However, the resistance rates to ciprofloxacin were different from 20% to 100% in Korea [10,12,13]. In this case, C. fetus was susceptible to ciprofloxacin.

In this case, the portal of entry of C. fetus is unclear, but might be due to infectious colitis. The patient was diagnosed with infectious colitis in the colonoscopy. Also, abdominal CT showed edematous wall thickening of sigmoid colon and peritoneal dialysate in perihepatic space and pelvic cavity. These findings suggest that intestinal bacteria may have spread into the peritoneal cavity. Inappropriate use of peritoneal catheter or exit- site infection can also increase the risk of CAPD peritonitis [5,14].

Nearly all patients without compromised or systemic infection recover from C. fetus gastroenteritis, especially without antibiotic therapy. However, immunocompromised persons or those with bacteremia or other extra-intestinal infection may require a prolonged course of antimicrobial treatment. Endovascular infections and immunocompromised patients with systemic infections due to C. fetus should be treated for at least four weeks. Persistent or relapsing infection with C. fetus can occur even years after the initial diagnosis [2,11]. In this case, although C. fetus was not recovered from CAPD fluid on 2nd peritonitis event, the recurrent infection due to C. fetus might be suspicious. It is significant that this is the first case report of CAPD peritonitis caused by C. fetus in Korea.

요약

Campylobacter fetus는 패혈증, 복막염, 뇌수막염, 심내막염, 화농성 관절염, 봉와직염, 유산을 일으킬 수 있고, 위장염도 드물게 일으킨다. 본 저자들은 지속복막투석법(CAPD) 치료를 받는 환자의 투석액에서 C. fetus를 16S rRNA 유전자 염기 서열 분석법으로 동정한 증례를 보고하고자 한다. 본 증례는 C. fetus에 의한 드물게 보고되는 CAPD 복막염으로 국내 첫 증례보고이다. [Ann Clin Microbiol 2018;21:20-22]

ACKNOWLEDGEMENTS

This work was supported by the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1468 and HI13C0866).

REFERENCES

1 JC Schefold, D Hasper, HD Volk, P Reinke.  Sepsis: time has come to focus on the later stages.  Med Hypotheses  2008;71:203 -8.    

2 G Gherardi, S Angeletti, M Panitti, A Pompilio, Bonaventura G Di, F Crea, al et.  Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates.  Diagn Microbiol Infect Dis  2012;72:20 -31.    

3 J Barenfanger, C Drake, G Kacich.  Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing.  J Clin Microbiol  1999;37:1415 -8.      

4 MJ Munoz-Dávila, G Yagüe, M Albert, T García-Lucas.  Comparative evaluation of Vitek 2 identification and susceptibility testing of Gram-negative rods directly and isolated from BacT/ALERT-positive blood culture bottles.  Eur J Clin Microbiol Infect Dis  2012;31:663 -9.    

5 AM Bazzi, AA Rabaan, MM Fawarah, JA Al-Tawfiq.  Direct identification and susceptibility testing of positive blood cultures using high speed cold centrifugation and Vitek II system.  J Infect Public Health  2017;10:299 -307.    

6 SJ Jo, KG Park, K Han, DJ Park, YJ Park.  Direct identification and antimicrobial susceptibility testing of bacteria from positive blood culture bottles by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and the Vitek 2 system.  Ann Lab Med  2016;36:117 -23.      

7 MR Pulido, M García-Quintanilla, R Martín-Peña, JM Cisneros, MJ McConnell.  Progress on the development of rapid methods for antimicrobial susceptibility testing.  J Antimicrob Chemother  2013;68:2710 -7.    

8 TK Ling, ZK Liu, AF Cheng.  Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gramnegative bacilli from positive blood cultures.  J Clin Microbiol  2003;41:4705 -7.      

9 Cueto M de, E Ceballos, L Martinez-Martinez, EJ Perea, A Pascual.  Use of positive blood cultures for direct identification and susceptibility testing with the Vitek 2 system.  J Clin Microbiol  2004;42:3734 -8.      

10 M Ligozzi, C Bernini, MG Bonora, Fatima M De, J Zuliani, R Fontana.  Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci.  J Clin Microbiol  2002;40:1681 -6.      

11 G Funke, P Funke-Kissling.  Use of the BD PHOENIX Automated Microbiology System for direct identification and susceptibility testing of gram-negative rods from positive blood cultures in a three-phase trial.  J Clin Microbiol  2004;42:1466 -70.      

12 JR Chen, SY Lee, BH Yang, JJ Lu.  Rapid identification and susceptibility testing using the VITEK 2 system using culture fluids from positive BacT/ALERT blood cultures.  J Microbiol Immunol Infect  2008;41:259 -64.

13 J Choi, HY Jeong, GY Lee, S Han, S Han, B Jin, al et.  Direct, rapid antimicrobial susceptibility test from positive blood cultures based on microscopic imaging analysis.  Sci Rep  2017;7:1148    

14 J Choi, J Yoo, M Lee, EG Kim, JS Lee, S Lee, al et.  A rapid antimicrobial susceptibility test based on single-cell morphological analysis.  Sci Transl Med  2014;6:267ra174    

15  CLSI.  Performance standards for antimicrobial susceptibility testing: Twenty-four informational supplement.  CLSI document M100-S24  24;:

16 SA Mittman, RC Huard, P Della-Latta, S Whittier.  Comparison of BD Phoenix to Vitek 2, MicroScan MICroSTREP, and Etest for antimicrobial susceptibility testing of Streptococcus pneumoniae.  J Clin Microbiol  2009;47:3557 -61.      

17 DS Hansen, AG Jensen, N Nørskov-Lauritsen, R Skov, B Bruun.  Direct identification and susceptibility testing of enteric bacilli from positive blood cultures using VITEK (GNI+/GNS-GA).  Clin Microbiol Infect  2002;8:38 -44.    

18 A Lupetti, S Barnini, P Morici, E Ghelardi, PH Nibbering, M Campa.  Saponin promotes rapid identification and antimicrobial susceptibility profiling of Gram-positive and Gram-negative bacteria in blood cultures with the Vitek 2 system.  Eur J Clin Microbiol Infect Dis  2013;32:493 -502.    

19 EA Idelevich, I Schüle, B Grünastel, J Wüllenweber, G Peters, K Becker.  Acceleration of antimicrobial susceptibility testing of positive blood cultures by inoculation of Vitek 2 cards with briefly incubated solid medium cultures.  J Clin Microbiol  2014;52:4058 -62.      

20 WJ Howard, BJ Buschelman, MJ Bale, MA Pfaller, FP Koontz, RN Jones.  Vitek GPS card susceptibility testing accuracy using direct inoculation from BACTEC 9240 blood culture bottles.  Diagn Microbiol Infect Dis  1996;24:109 -12.  

21 GL Woods, D LaTemple, C Cruz.  Evaluation of MicroScan rapid gram-positive panels for detection of oxacillin-resistant staphylococci.  J Clin Microbiol  1994;32:1058 -9.